Use of 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) -ethoxy) benzyl) 2,4-thiazide lidiodione in the treatment of polycystic ovary syndrome and diabetes due to pregnancy

摘要

Invention Patent: B "USE OF 5- (4- (2- (N-METHYL-N- (2-PYRIDIL) AMINO) -E-TOXI) BENZIL) 2,4-TIAZO LIDINODIONA IN THE TREATMENT OF POLICYSTIC SYNDROME OF OVÁRIO AND DIABETES ARISING FROM PREGNANCY "D. This invention presents new methods of using thiazolidinone derivatives and related anti-hyperglycemic agents to treat populations at risk of developing non-insulin-dependent diabetes mellitus (NIDDM) and complications arising from it. In one embodiment, the compounds of the invention are used to treat polycystic ovary syndrome in order to prevent or delay the onset of non-insulin-dependent diabetes mellitus. In another embodiment, the compounds of the invention are used to treat diabetes resulting from pregnancy in order to prevent or delay the onset of non-insulin-dependent diabetes mellitus.